Mednet Logo
HomePrimary CareQuestion

Is there an age cutoff where you consider the risks of monoclonal antibody therapy outweigh any potential benefit(s) in early-onset dementia?

1 Answers
Mednet Member
Mednet Member
Psychiatry · McLean Hospital/Harvard Medical School

A brief discussion of dementia terminology is worthwhile to avoid confusion regarding diagnostic classification and treatment rationale.

As is well known, there are many dementias, and the descriptor “early onset” can be used for childhood dementias, such as Rett syndrome, and also for disorders suc...

Register or Sign In to see full answer